QIAGEN NV is a pharmaceutical company based in the Netherlands. With a low-risk ESG score of 13.5, QIAGEN NV specializes in offering sample and assay technology for DNA, RNA, and proteins. They generate revenue from consumables and instrumentation services, with a strong presence in the Americas, EMEA, and Asia-Pacific regions.